1 Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden.
2 Pediatric Oncology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden.
3 ECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
4 Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
5 Institution of Clinical Sciences, Department of Pediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.
6 Department of Anesthesia, Södertälje Hospital, Södertälje, Sweden.
7 Department of Anaesthesia and Intensive Care, Karolinska Institutet at Danderyd Hospital (KIDS), Danderyd, Sweden.
8 Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
9 Department of Women’s and Children’s Health, Uppsala University and Pediatric Oncology, Uppsala University Hospital, Uppsala, Sweden.
10 Department of Pediatric Oncology, Skåne University Hospital, Lund University, Lund, Sweden.
11 Department of Pediatrics, Linköping University Hospital, Linköping, Sweden.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/pccmjournal).
Supported by the Swedish Childhood Cancer Foundation (to Drs. Ranta and Heyman) and, in part, by the Stockholm County Council (Medical Training and Research Agreement (ALF project).
Dr. Ranta’s institution received funding from the Stockholm County Council, the Swedish Childhood Cancer Foundation, Swedish Orphan Biovitrum AB, and Pediatric Network on haemophilia management; she received support for article research from the Stockholm County Council (ALF project). Drs. Ranta and Heyman received support for article research from the Swedish Childhood Cancer Foundation. Dr. Broman received funding from Eurosets and Xenios. Dr. Abrahamsson received support for article research from the Children’s Cancer Foundation Sweden. Dr. Heyman’s institution received funding from Servier and Pfizer. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
